Recent Finacing
Recent Raise
AavantiBio is a Cambridge-based gene therapy company developing treatments for rare inherited disorders, with a lead Friedreich’s ataxia program built on founders’ UF research and clinical partnerships.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at AavantiBio.
